To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Pharma and biotech companies spend billions of dollars each year to acquire genomic data. Scientists need large genomic datasets to identify causes of disease and develop cures. However, growth of the genomic data market is hindered by small data quantities, data fragmentation, lack of data standardization and slow data acquisition.
Nebula Genomics will leverage blockchain technology to eliminate the middleman and empower people to own their personal genomic data. This will effectively lower sequencing costs and enhance data privacy, resulting in growth of genomic data. Our open protocol will leverage the genomic data growth by enabling data buyers to efficiently aggregate standardized data from many individuals and genomic databanks.
- 1Intas Biopharmaceuticals Ltd.
- 2Ranbaxy Laboratories Ltd.
- 3Life Technologies Corporation
- 4Autobio Diagnostics Co., Ltd
- 5BIOTON S.A.
- 6Sanofi-Aventis Deutschland GmbH
- 7Abbott GmbH & Co. KG
- 8Scientis Pharma SA
- 9LPT - Laboratory of Pharmacology and Toxicology GmbH & Co. KG
- 10MEDICE Arzneimittel Pütter GmbH & Co. KG